Dexamethasone reduces androgen levels in metformin-treated patients with polycystic ovary syndrome
- 29 February 2004
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 81 (2), 459-462
- https://doi.org/10.1016/j.fertnstert.2003.06.022
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndromeFertility and Sterility, 1998
- Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary SyndromeObstetrics & Gynecology, 1997
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeThe New England Journal of Medicine, 1996
- Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancyMetabolism, 1994
- Hyperprolactinemia and Polycystic Ovarian SyndromeSeminars in Reproductive Medicine, 1992
- Prolactin secretion in polycystic ovary syndrome: circadian rhythmicity and dynamic aspectsGynecological Endocrinology, 1988
- EFFECT OF BROMOCRIPTINE ON LH PULSATILITY IN THE POLYCYSTIC OVARY SYNDROMEClinical Endocrinology, 1987
- A Double Blind Controlled Study of the Hormonal and Clinical Effects of Bromocriptine in the Polycystic Ovary Syndrome*Journal of Clinical Endocrinology & Metabolism, 1986
- STUDIES OF PROLACTIN SECRETION IN POLYCYSTIC OVARY SYNDROMEClinical Endocrinology, 1986
- Adrenal Abnormalities in Polycystic Ovary Syndrome*Journal of Clinical Endocrinology & Metabolism, 1986